Skip to main content
American Journal of Respiratory and Critical Care Medicine logoLink to American Journal of Respiratory and Critical Care Medicine
letter
. 2020 Dec 15;202(12):1727–1731. doi: 10.1164/rccm.202004-1086LE

Supraglottic Lung Microbiome Taxa Are Associated with Pulmonary Abnormalities in an HIV Longitudinal Cohort

Jin J Zhou 1,*,, Jing Zhai 1,, Hua Zhou 2, Yin Chen 1, Stefano Guerra 1, Ian Robey 1, George M Weinstock 3, Erica Weinstock 3, Qunfeng Dong 4, Kenneth S Knox 5, Homer L Twigg III 6
PMCID: PMC7737582  PMID: 32783620

To the Editor:

Lung microbiome analysis of acellular BAL suggests the presence of two distinct lung pneumotypes, background predominant taxa (BPT) and supraglottic predominant taxa (SPT) (1, 2). The latter has been shown to be associated with a distinct metabolic profile and a T-helper cell type 17 proinflammatory phenotype among healthy individuals (2). We have previously demonstrated an altered lung microbiome in HIV-infected subjects, including persistent increases in taxa associated with pneumotypeSPT (3). However, the lung inflammatory profile and associated lung function has not been elucidated. In this work, we investigated associations between lung function, inflammation, and lung microbiome dysbiosis in an HIV-positive population with relatively advanced disease who were studied at baseline and over a 1-year follow-up.

Our study population consisted of 30 HIV-infected, treatment-naive adults who underwent analysis of lung inflammatory mediators and pulmonary function testing before antiretroviral therapy (ART) and again at 4 weeks and 1 year after starting ART (3). As previously reported (3), these subjects had advanced HIV disease at baseline (median and interquartile range of CD4 is 280 and 92–385) and had sustained viral control and improved CD4 counts after starting ART. Forty-eight genera had a relative abundance ≥2% and were included in this analysis. Taxa were then classified as either BPT or SPT based on previous classification (1, 2). Taxa not classified in these prior reports were included in the SPT group if they were known common oropharyngeal organisms. Taxa not described in these reports were placed in the BPT group if prior published work demonstrated they were not common oral taxa or left as unclassified or not defined taxa if no data were available linking them to a human compartment. In general, pneumotypeSPT was dominated by supraglottic phyla such as Bacteroidetes, Firmicutes, and Fusobacterium, whereas pneumotypeBPT was enriched with background predominant phyla such as Proteobacteria and Actinobacteria. The pairwise correlation between genera at baseline (before ART) and at 4 weeks and 1 year after ART is shown in Figure 1. Most (>80%) pairwise correlations between taxa within the pneumotypeSPT subgroup were positive (Figures 1A–1C). Correlations between pneumotypeBPT taxa were weaker, and the majority of the correlations between pneumotypeSPT and pneumotypeBPT were negative for all three time points. The negative correlation between pneumotypeSPT and pneumotypeBPT increased after receiving ART. These data suggest that taxa within pneumotypeSPT are relatively uniform and stable over time, reflecting organisms found in the oral cavity. In contrast, taxa within pneumotypeBPT are much more variable and likely influenced by environmental factors. Consistent with prior reports (4), adjusting for smoking had no significant effects on the respiratory microbiome.

Figure 1.

Figure 1.

Figure 1.

Heat map of Spearman correlation between genera at (A) baseline. (B) Four weeks after baseline. (C) One year after baseline. Spearman’s ρ correlation matrix was reordered by the hierarchical clustering algorithm with complete agglomeration. Red color represents positive correlation, whereas blue color shows negative correlation. Genera in pneumotypeBPT are in dark cyan font, and genera in pneumotypeSPT are in dark pink font. Dark gray font represents not defined pneumotype taxa. (D) A cooccurrence network of genus-level taxa generated by the SparCC (Sparse Correlation for Compositional Data) package and visualized by Cytoscape 3.2.6. Cooccurrences were assessed by significant weighted Spearman’s ρ calculated using all time points with permutation P < 0.05 and ρ > 0.6. Genera identified as pneumotypeBPT are in light blue, and genera identified as pneumotypeSPT are in light pink. The undefined genera are in light gray. The lung function parameters and inflammation markers are in yellow and purple, respectively. The dark red line indicates the positive association; the green line indicates the negative association. BPT = background predominant taxa; DsbHb = DlCO corrected for hemoglobin; FEF = forced expiratory flow; IP-10 = IFN-inducible protein 10; MCP-1 = monocyte chemoattractant protein-1; SPT = supraglottic predominant taxa.

A weighted Spearman correlation for repeated measures, using the number of observations as weights, was used to assess the association of taxa abundance with inflammatory markers as well as with lung function measurements (5). With the exception for Granulicatella, pneumotypeSPT taxa were positively associated with BAL proinflammatory cytokines (Table 1, top panel). It is worth noting that Tropheryma, which would be classified as BPT as it is not a typical supraglottic organism (6), was associated with greater inflammation. The only other pneumotypeBPT organism associated with lung inflammation was Moraxella, a known respiratory tract pathogen. Eleven genera were significantly associated with at least one spirometry or diffusion capacity measurement (i.e., FEV1; FVC; forced expiratory flow, midexpiratory phase; and DlCO corrected for hemoglobin shown in Table 1, bottom panel). Among them, six genera were pneumotypeSPT, three were pneumotypeBPT, and two did not belong to either group. Overall, pneumotypeBPT genera Burkholderia and Propionibacterium were significantly associated with better lung function in both spirometry and diffusion capacity. In contrast, except Neisseria, pneumotypeSPT taxa were associated with poorer lung function. Finally, we constructed a cooccurrence network using the SparCC (Sparse Correlation for Compositional Data) package (7) among genus-level taxa with significant associations with inflammatory cytokines, chemokines, and pulmonary function outcomes (Figure 1D). Genera within pneumotypeSPT and pneumotypeBPT cooccurred with each other, forming two well-defined clusters. Additionally, most genera in pneumotypeSPT (5 out of 8) were significantly correlated with chemokine/cytokine levels. In contrast, most SPT-characteristic genera (5 out of 6) were negatively correlated with lung function except for Neisseria. Similar results were observed if each time point was analyzed separately.

Table 1.

Genera Significantly Associated with Chemokine or Cytokine Levels and Lung Function

Pneumotype Genus Phylum Chemokine or Cytokine* Weighted Spearman’s ρ (95% CI)*
BPT Moraxella Proteobacteria IL-8 0.485 (0.151 to 0.719)
  Tropheryma Actinobacteria MCP-1 0.438 (0.093 to 0.690)
      IL-6 0.415 (0.064 to 0.674)
SPT Filifactor Firmicutes IL-8 0.662 (0.396 to 0.825)
      IP-10 0.463 (0.123 to 0.705)
      MIG 0.673 (0.413 to 0.832)
      IL-6 0.384 (0.027 to 0.654)
  Granulicatella Firmicutes MCP-1 −0.369 (−0.644 to −0.011)
      IL-6 −0.448 (−0.696 to −0.105)
  Gemella Firmicutes MIG 0.363 (0.003 to 0.639)
  Selenomonas Firmicutes IL-6 0.415 (0.064 to 0.674)
  Treponema Spirochaetes IL-8 0.434 (0.088 to 0.687)
NDT Sneathia Fusobacteria MIG 0.367 (0.008 to 0.643)
Pneumotype Genus Phylum Lung Function Weighted Spearman’s ρ (95% CI)*
BPT Burkholderia Proteobacteria FEV1 0.494 (0.163 to 0.725)
      FVC 0.538 (0.221 to 0.752)
      DsbHb 0.529 (0.209 to 0.747)
  Corynebacterium Actinobacteria FVC 0.433 (0.086 to 0.686)
  Propionibacterium Actinobacteria FEV1 0.361 (0.001 to 0.638)
      FVC 0.445 (0.101 to 0.694)
      DsbHb 0.650 (0.379 to 0.819)
      DsbHb% predicted 0.569 (0.262 to 0.771)
SPT§ Filifactor Firmicutes FEF25–75 −0.419 (−0.677 to −0.069)
  Neisseria Proteobacteria DsbHb 0.490 (0.158 to 0.723)
      DsbHb% predicted 0.596 (0.301 to 0.787)
  Oribacterium Firmicutes FEV1 −0.418 (−0.676 to −0.068)
  Porphyromonas Bacteroidetes FEV1% predicted −0.392 (−0.659 to −0.037)
      FVC% predicted −0.370 (−0.644 to −0.011)
  Rothia Actinobacteria FEV1/FVC −0.422 (−0.679 to −0.072)
  Treponema Spirochaetes FEF25–75 −0.440 (−0.691 to −0.094)
      FEF% predicted −0.475 (−0.713 to −0.139)
NDT Moryella Firmicutes FEV1 −0.368 (−0.643 to −0.008)
      FVC −0.410 (−0.671 to −0.058)
  Capnocytophaga Bacteroidetes DsbHb% predicted 0.411 (0.059 to 0.672)

Definition of abbreviations: BPT = background predominant taxa; CI = confidence interval; DsbHb = DlCO corrected for hemoglobin; FEF = forced expiratory flow; FEF25–75 = forced expiratory flow, midexpiratory phase; IP-10 = IFN-inducible protein 10; MCP-1 = monocyte chemoattractant protein-1; NDT = not defined taxa; SPT = supraglottic predominant taxa.

*

Weighted Spearman’s ρ that are larger than 2 SDs from mean were shown in the table.

A permutation test was adopted to evaluate the enrichment of positive or negative associations (defined by Spearman’s ρ with larger than 2 SDs from mean) among SPT genera with chemokine/cytokine or lung function levels. Ten thousand permutation replicates were used.

Permutation P = 0.082.

§

Permutation P < 0.000.

In this study, we defined lung microbiome pneumotypes based on prior publications (1, 2). PneumotypeSPT taxa are likely derived from the oral cavity and supraglottic region, considered widely as representing a true lower respiratory tract microbiome that have the potential to cause local inflammation. All other taxa have traditionally been grouped in the BPT pneumotype and are felt to represent “background” organisms. Our results highlight strengths and caveats to this paradigm, particularly in the context of HIV. The significant positive correlations between oropharyngeal taxa in Figures 1A–1C strongly support the concept of a supraglottic pneumotype. The lack of correlation between BPT taxa emphasizes that in the absence of SPT taxa, the pneumotypeBPT tends to be unique in different individuals. However, the concept that the pneumotypeBPT represents just background taxa needs to be reexamined. First, Tropheryma whipplei, a pneumotypeBPT taxa, was associated with lung inflammation. Widespread colonization of Tropheryma has been reported in the lungs of HIV-infected subjects and is dramatically reduced with ART (6). Although we classified Tropheryma as pneumotypeBPT as it has not been found in the oral cavity when sampled from oral washings (6), this organism is known to be present in the gastrointestinal tract, where it may cause Whipple’s disease. As such, Tropheryma is likely entering the lung compartment through the blood after translocation from the gut. Moraxella is another example of a taxa that was included in the BPT group but is clearly associated with lung inflammation in our cohort. Moraxella is a known lower respiratory tract pathogen that can cause lower airway inflammation. Even though they do not fall into the SPT category, certain groups of Moraxella (e.g., Moraxella catarrhalis) are known lung pathogens (8). These results highlight the fact that although most background taxa do not cause lung inflammation, there are instances through which bacteria not usually found in the supraglottic space may gain access to the lower respiratory tract and be associated with inflammation. The beneficial effect of some BPT taxa with lung function is intriguing. Whether this represents a true protective effect or just the absence of SPT bacteria requires further study. Finally, this work supports the paradigm that the presence of supraglottic taxa in the lower respiratory tract resulting from chronic low-grade aspiration seen in virtually all humans may be a susceptibility marker to chronic lung diseases seen in both HIV-infected subjects and non–HIV-infected aging population. This paradigm is further supported by recent work (9).

In conclusion, we demonstrated that there are significant correlations among lung microbiome composition, lower respiratory tract inflammation, and lung function in patients living with HIV. Our findings contribute to a growing body of work demonstrating correlations between the host microbiome and chronic disease (10), with implications for both the HIV-infected and HIV-uninfected population.

Supplementary Material

Supplements
Author disclosures

Footnotes

H.L.T. is supported by NIH grant U01HL098960; K.S.K. by NIH grant R01HL83468; and J.J.Z. by NIH grants K01DK106116, 1R21HL150374-01A1, and 2R01HG006139-08A1 and an Arizona Biomedical Research Commission grant. H.Z. is partially supported by NIH grants HG006139 and GM53275 and National Science Foundation grant DMS-1645093, and Y.C. is partly supported by NIH grants ES027013, ES028889, and AI39439.

Author Contributions: Conception and design: J.J.Z., J.Z., K.S.K., and H.L.T. Analysis and interpretation: J.J.Z., J.Z., H.Z., Y.C., S.G., G.M.W., K.S.K., and H.L.T. Drafting the manuscript for important intellectual content: J.J.Z., J.Z., H.Z., Y.C., S.G., G.M.W., K.S.K., and H.L.T. Data generation and quality control: I.R., G.M.W., E.W., Q.D., K.S.K., H.L.T.

Originally Published in Press as DOI: 10.1164/rccm.202004-1086LE on August 12, 2020

Author disclosures are available with the text of this letter at www.atsjournals.org.

References

  • 1.Segal LN, Alekseyenko AV, Clemente JC, Kulkarni R, Wu B, Gao Z, et al. Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation. Microbiome. 2013;1:19. doi: 10.1186/2049-2618-1-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Segal LN, Clemente JC, Tsay JC, Koralov SB, Keller BC, Wu BG, et al. Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype. Nat Microbiol. 2016;1:16031. doi: 10.1038/nmicrobiol.2016.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Twigg HL, III, Knox KS, Zhou J, Crothers KA, Nelson DE, Toh E, et al. Effect of advanced HIV infection on the respiratory microbiome. Am J Respir Crit Care Med. 2016;194:226–235. doi: 10.1164/rccm.201509-1875OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Morris A, Beck JM, Schloss PD, Campbell TB, Crothers K, Curtis JL, et al. Lung HIV Microbiome Project. Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med. 2013;187:1067–1075. doi: 10.1164/rccm.201210-1913OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Bland JM, Altman DG. Calculating correlation coefficients with repeated observations: part 2. Correlation between subjects. BMJ. 1995;310:633. doi: 10.1136/bmj.310.6980.633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Lozupone C, Cota-Gomez A, Palmer BE, Linderman DJ, Charlson ES, Sodergren E, et al. Lung HIV Microbiome Project. Widespread colonization of the lung by Tropheryma whipplei in HIV infection. Am J Respir Crit Care Med. 2013;187:1110–1117. doi: 10.1164/rccm.201211-2145OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Friedman J, Alm EJ. Inferring correlation networks from genomic survey data. PLOS Comput Biol. 2012;8:e1002687. doi: 10.1371/journal.pcbi.1002687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Narinesingh SP, Whitby DJ, Davenport PJ. Moraxella catarrhalis: an unrecognized pathogen of the oral cavity? Cleft Palate Craniofac J. 2011;48:462–464. doi: 10.1597/09-054. [DOI] [PubMed] [Google Scholar]
  • 9.Yang L, Dunlap DG, Qin S, Fitch A, Li K, Koch CD, et al. Alterations in oral microbiota in HIV are related to decreased pulmonary function. Am J Respir Crit Care Med. 2020;201:445–457. doi: 10.1164/rccm.201905-1016OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Gilbert JA, Quinn RA, Debelius J, Xu ZZ, Morton J, Garg N, et al. Microbiome-wide association studies link dynamic microbial consortia to disease. Nature. 2016;535:94–103. doi: 10.1038/nature18850. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplements
Author disclosures

Articles from American Journal of Respiratory and Critical Care Medicine are provided here courtesy of American Thoracic Society

RESOURCES